- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BeBetter Med Inc (688759)
Track today's live BeBetter Med (688759) share price, performance and key data on this page with our current Shanghai:688759 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the BeBetter Med share price on the Shanghai exchange. Use the dropdown to switch exchange for the 688759 share price, head to our technical summary section, which provides analysis on BeBetter Med share price buy/sell indicators using real-time data (or discuss the BeBetter Med (688759) stock price today with other investors in the BeBetter Med SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS:688759 share price (ISIN: CNE100007CZ3) to enhance your trading decisions with our free investment tools and resources.
What Is the BeBetter Med Inc Share Price Today?
The BeBetter Med share price today is 28.16.
What Is the Stock Symbol for BeBetter Med Inc
The stock symbol (or 'ticker') for BeBetter Med Inc is "688759."
What Stock Exchange Does BeBetter Med Inc Trade On?
BeBetter Med Inc is listed and trades on the Shanghai stock exchange.
Is BeBetter Med Inc a Good Stock to Buy?
Determining whether BeBetter Med (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current SS:688759 share price (ISIN: CNE100007CZ3) to enhance your trading decisions with our free investment tools and resources.
What Is the BeBetter Med Inc Share Price Today?
The BeBetter Med share price today is 28.16.
What Is the Stock Symbol for BeBetter Med Inc
The stock symbol (or 'ticker') for BeBetter Med Inc is "688759."
What Stock Exchange Does BeBetter Med Inc Trade On?
BeBetter Med Inc is listed and trades on the Shanghai stock exchange.
Is BeBetter Med Inc a Good Stock to Buy?
Determining whether BeBetter Med (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Shanghai
Currency in CNY
28.16
-0.09(-0.32%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.50
28.65
52 wk Range
20.70
57.47
688759 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.5028.65
52 wk Range
20.7057.47
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688759 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
50.22
Upside
+78.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 50.22
(+78.34% Upside)
Earnings
Latest Release
27/04/2026
EPS / Forecast
-0.12 / --
Revenue / Forecast
-- / --
Compare 688759 to Peers and Sector
Metrics to compare | 688759 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688759PeersSector | |
|---|---|---|---|---|
P/E Ratio | −74.3x | 31.8x | −0.4x | |
PEG Ratio | - | 0.02 | 0.00 | |
Price/Book | 7.8x | 3.2x | 2.6x | |
Price / LTM Sales | - | 7.5x | 3.1x | |
Upside (Analyst Target) | 78.3% | 5.3% | 47.8% | |
Fair Value Upside | Unlock | 20.0% | 6.2% | Unlock |
BeBetter Med Inc., a biopharmaceutical company, engages in the research and development, and sale of drugs for oncology, metabolic diseases and central nervous system degenerative diseases. It offers BEBT-908, a PI3K/HDAC dual-target small molecule inhibitor for antitumor; developing BEBT-209, a CDK4/6 selective inhibitor for metastatic triple-negative breast cancer; and BEBT-109, a selective EGFR inhibitor designed for NSCLC. The company also develops BEBT-503, an oral, well-balanced pan-PPAR for metabolic diseases including diabetes and mash; BEBT-507, a GalNAc-siRNA drug for Polycythemia Vera (PV); and BEBT-701, a GalNAc-siRNA therapeutic for treatment of hypertension with co-existing hyperlipidemia. In addition, it provides BEBT-809, a small molecule inhibitor for obesity; BEBT-706, for ASCVD risk reduction; BEBT-720, for mash; BEBT-758, for the treatment of Parkinson's disease; BEBT-756, for Alzheimer's disease; BEBT-730, for hyperuricemia and gout; BEBT-733, for renal anemia/CKD; and BEBT-738, for diabetes. The company was founded in 2012 and is based in Guangzhou, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BeBetter Med (Shanghai: 688759) Share Price Today?
The BeBetter Med stock price today is 28.16 CNY.
What Stock Exchange Does BeBetter Med (688759) Trade On?
BeBetter Med is listed and trades on the Shanghai Stock Exchange.
What Is the Ticker (Stock Symbol) for BeBetter Med?
The stock symbol (also called a 'ticker') for BeBetter Med is "688759."
What Is the Current BeBetter Med Market Capitalisation?
As of today, BeBetter Med (Shanghai: 688759) market cap is 12.67B CNY.
What Is BeBetter Med's (688759) Earnings Per Share (TTM)?
The BeBetter Med EPS is currently -0.42 (Trailing Twelve Months).
Is 688759 a Buy or Sell From a Technical Analyst Perspective?
Based on today's BeBetter Med moving averages and other technical indicators, the daily buy/sell signal for 688759 stock is Buy.
How Many Times Has BeBetter Med Stock Split?
BeBetter Med has split 0 times. (See the 688759 stock split history page for full effective split date and price information.)
How Many Employees Does BeBetter Med Have?
BeBetter Med has 160 employees, based on their latest Companies House report.
What is the current trading status of BeBetter Med (Shanghai: 688759)?
As of 15/08/2026, BeBetter Med (688759) is trading at a share price of 28.16 CNY, with a previous close of 28.25 CNY. The stock has fluctuated within a day range of 27.50 CNY to 28.65 CNY, while its 52-week range spans from 20.70 CNY to 57.47 CNY.
What Is BeBetter Med (688759) Price Target According to Analysts?
The average 12-month price target for BeBetter Med is 50.22 CNY, with a high estimate of 50.22 CNY and a low estimate of 50.22 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +78.34% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.